Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Case of Isolated Cervicomedullary Injury With Extensive Wallerian Degeneration: The Multifactorial Nature in Making Decisions to Withdraw Life Support From a Pathology Perspective.

Cureus·2026
Same author

Assessment of pain and functional outcomes after lower limb amputation: a scoping review.

BMJ open·2026
Same author

A 3D-Printed Rupture-Prone Aneurysm Model for Assessing the Safety and Efficacy of Endovascular Devices.

Journal of biomedical materials research. Part B, Applied biomaterials·2026
Same author

High-fidelity measurement of pulse arrival time in critically ill children using standard bedside monitoring equipment.

Physiological measurement·2025
Same author

Quality and Safety Initiatives in a Pediatric and Congenital Heart Surgery Program in a Lowand Middle-Income Country: The Impact of International Collaboration.

Brazilian journal of cardiovascular surgery·2025
Same author

Pump Versus Syringe: Aspiration Thrombectomy Direct Pressure Comparisons in a Comprehensive Benchtop 3-Dimensional-Printed Circle of Willis Model.

Operative neurosurgery (Hagerstown, Md.)·2025

Related Experiment Video

Updated: Jul 4, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
08:47

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration

Published on: February 10, 2012

Targeting nicotine addiction in a substance abuse program.

James R Sharp1, Steven Schwartz, Thomas Nightingale

  • 1Van Dyke Addiction Treatment Center, Ovid, New York 14521, USA. JimSharp@oasas.state.ny.us

Science & Practice Perspectives
|June 17, 2008
PubMed
Summary

Integrating nicotine addiction treatment into substance dependency programs improves patient outcomes. This approach can lead to better responses to other addiction interventions and reduced long-term tobacco-related health issues.

Related Experiment Videos

Last Updated: Jul 4, 2026

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
08:47

Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration

Published on: February 10, 2012

Area of Science:

  • Addiction Medicine
  • Public Health
  • Behavioral Science

Background:

  • Nicotine addiction is a significant comorbidity in patients with substance use disorders.
  • Addressing nicotine use concurrently with other substance dependencies may enhance overall treatment efficacy.
  • Tobacco-free policies in treatment facilities are increasingly being implemented.

Purpose of the Study:

  • To evaluate the impact of integrating nicotine addiction interventions and tobacco-free policies in inpatient substance dependency treatment programs.
  • To assess changes in treatment completion rates following policy implementation.
  • To identify challenges and future research needs related to these integrated approaches.

Main Methods:

  • Review of experiences from three inpatient substance dependency treatment programs.
  • Implementation of nicotine addiction interventions and facility-wide tobacco-free policies.
  • Analysis of treatment completion rates before and after policy adjustments.

Main Results:

  • Two of the three programs reported higher overall treatment completion rates post-implementation.
  • Initial adverse effects were observed but were managed through policy adjustments.
  • The integration of nicotine interventions showed potential for improving patient outcomes.

Conclusions:

  • Addressing nicotine addiction as part of substance dependency treatment can yield significant benefits, including improved treatment completion.
  • Long-term studies are needed to fully understand the impact of tobacco-free treatment environments.
  • Further research should focus on cost-benefit analysis and tailoring interventions for diverse patient populations.